Cartesian Therapeutics Target Price

See how RNAC's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.03

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-12	H.C. Wainwright	$25	211.3% upside
2026-03-09	Cantor Fitzgerald	$16	99.3% upside
2024-08-09	H.C. WainwrightMitchell Kapoor	$45	460.4% upside
2024-07-03	Canaccord GenuityJohn Newman	$43	435.5% upside
2024-05-24	Mizuho SecuritiesUy Ear	$40	398.1% upside

Cartesian Therapeutics (RNAC) FAQ

Stockcircle tracks target price for Cartesian Therapeutics (RNAC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Cartesian Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RNAC overview so you can move from this figure to the surrounding analysis quickly.